Enjoy complimentary customisation on priority with our Enterprise License!
The global women's health diagnostics market size is estimated to grow by USD 13.35 billion at a CAGR of 7.93% between 2022 and 2027. The increasing prevalence of breast cancer, driven by various factors including lifestyle changes and aging populations, is driving market growth by increasing the demand for breast cancer screening, diagnosis, and treatment options. The increasing infertility rate in women, attributed to factors such as delayed childbearing and lifestyle factors, is also boosting market expansion by creating a demand for fertility treatments and services. Additionally, the increasing prevalence of sexually transmitted diseases (STDs), driven by changes in sexual behavior and inadequate access to healthcare, is driving the demand for STD testing, treatment, and prevention products.
STDs are caused by the transmission of different bacteria, viruses, and parasites due to the exchange of vaginal fluids. There are more than 30 different bacteria, viruses, and parasites that can cause STDs. All through life, STDs have had a disproportionately negative impact on women. Syphilis, gonorrhea, chlamydia, hepatitis B, genital herpes, and HIV are among the several STDs. Major contributors to pelvic inflammatory illness and infertility in women are gonorrhea and chlamydia. The increasing incidences and prevalence of STDs are increasing the demand for screening and diagnosis of STDs at the earliest to reduce the chances of mortality. companies present across the globe are focusing on offering a wide range of STD-testing drugs.
To learn more about this report, Request Free Sample
This report provides a detailed analysis of the market by Application (Breast cancer testing, Infectious disease testing, STD testing, Cervical cancer testing, and Others ), End-user (Hospitals and clinics, Diagnostic and imaging centers, and Home care settings ), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
The market share growth by the breast cancer testing segment will be significant during the forecast period. A biopsy is the only reliable method for identifying breast cancer. The doctor performs a biopsy by using a specialized needle instrument to remove a core of tissue from the location while being guided by an X-ray or other imaging test.
Get a glance at the market contribution of various segments View a PDF Sample
The breast cancer testing segment was valued at USD 6.27 billion in 2017. Biopsy samples are analyzed in a laboratory to determine whether or not they contain cancer cells. The type of cells involved in breast cancer, its aggressiveness (grade), and whether the cancer cells have hormone receptors or other receptors that could affect treatment options are all determined by analyzing a biopsy sample.
Hospitals and clinics
Over the years, hospitals and clinics have developed advanced medical infrastructure to cater to the needs of people. One of the major focus areas in hospitals is to increase the screening, monitoring, and diagnosis of various chronic diseases, such as cervical cancer and breast cancer in outpatient settings. For women who do not have other sources of screening, the opportunity to perform diagnostic tests in a hospital or clinical setting is available. An accurate test for cancer, such as a biopsy test, during hospital admission, plays a vital role in reducing the mortality rates of breast and cervical cancer. With an increase in the number of hospitals and clinics and the increased convenience provided by them, they are expanding women's health diagnostic services related to infertility, gynecology, menopause, and others, which have provided patients with a broader range of treatment options to choose from based on cost and effectiveness. Also, with an increase in the number of hospitals and clinics, there is easier access to women's health diagnostic services.
Diagnostic and imaging centers
Due to the increasing prevalence of chronic and infectious diseases and associated risk factors among women, the rapidly growing elderly women population, and the increasing number of women health studies and surgical imaging procedures, the diagnostic and imaging center segment is expected to grow steadily during the forecast period. Diagnostic imaging, which supports the diagnosis and treatment of diseases, has rapidly evolved into a vital role in modern medicine. In addition, diagnostics and imaging equipment have been constantly developed by companies operating on the market. With the rising number of chronic diseases among women and investment in the healthcare sector, diagnostic and imaging centers will witness growth, which, in turn, is expected to propel the growth of the global market during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America has been witnessing an increase in the adoption of various advanced diagnostic technologies over the past few years. In this region, the majority of market growth is due to technological adoption, increasing health care expenditure, rising prevalence of diseases like cancer, and increased levels of awareness about breast cancer screening and diagnosis. This is one of the most common chronic diseases found in people in this region. According to the CDC, breast cancer is one of the most common types of cancer in women, and it is the second leading cause of cancer deaths among women in the US.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Abbott Laboratories, Becton Dickinson and Co. - The company offers women's health diagnostics such as menstrual medicine called Duphaston and Iberet Folic 500.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is crucial for addressing a range of conditions, including infectious diseases like hepatitis and urinary tract infections. Advanced diagnostic technologies such as digital and mobile mammography, breast MRI, and ultrasound play a vital role in the early detection of breast cancer. Additionally, diagnostics for osteoporosis through bone density testing are important for women's health. The market also focuses on sexual and reproductive health, including diagnostics for STDs and infertility. With a growing emphasis on preventive care, diagnostics for cancer and other conditions are gaining prominence. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The increasing prevalence of breast cancer is driving growth in the women's health diagnostics market. Cancer is a widespread chronic disease that is increasingly becoming a significant health concern, contributing to the rising global mortality rates. Among the various types of cancer, breast cancer stands out as one of the most common forms affecting women. The growing prevalence of breast cancer is closely linked to the expanding elderly population, as it is more commonly diagnosed in older women worldwide. This trend underscores the importance of regular screening and early detection methods such as digital and mobile mammography, breast MRI, ultrasound, and bone density testing, especially for women-centric conditions. To combat the impact of breast cancer, regular screening is essential for women globally to detect any signs or symptoms early and reduce mortality rates. The demand for screening has surged worldwide due to the escalating death rates associated with the disease. Healthcare professionals recommend and conduct diagnostic procedures such as X-rays or MRIs to detect breast cancer in patients, which is expected to drive market growth in the forecast period.
The adoption of advanced diagnostic solutions is a primary trend in the market. Breast cancer management and infectious disease testing using immunoassay and molecular diagnostic technologies are becoming more and more common. The availability of advanced treatment care also enables increased adoption rates among healthcare providers. The growth of specialist tests in esoteric, pathology, and genetic areas will continue to grow over the forecast period even though currently there is more activity associated with normal diagnostics. The increased need for diagnostic products encourages companies to focus on providing customized automation solutions to address the needs of patients.
Moreover, the adoption of point-of-care testing (POCT) is rising globally due to its efficient workflow process and advantages such as the ability to be performed at the bedside, portability, and timely and rapid diagnosis. Thus, the increasing adoption of advanced diagnostics solutions will propel the growth of the market focus during the forecast period.
The lack of trained laboratory technicians is a major challenge in the market challenge. Trained professionals with better dexterity skills, able to handle tools and perfectly perform procedures, are required for almost all of the critical diagnostics tests like immunoassays and molecular diagnosis. The need for expensive and multi-year theoretical studies to become qualified professionals or technicians also contributes to the shortage of trained laboratory technicians. An important role in the early detection and treatment of diseases is to be played by expertise and skills in handling and use of diagnostic tools.
Moreover, the market has a shortage of trained professionals who can handle technologically advanced diagnostic devices. The results of tests may be affected due to errors in data input, which can have an impact on diagnosis using automatic handling systems. The lack of expertise is likely to lead to an incorrect diagnosis. Trained professionals must handle automated handling systems, as accuracy and reliability play a vital role in laboratories. Hence, the limited number of trained staff will negatively affect market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The market is experiencing significant advancements, especially in breast cancer diagnosis and treatment facilities, aided by technologies like Digital Breast Tomosynthesis (DBT) and Imagio Breast Imaging System. There's a growing focus on fertility assessments and addressing menstrual abnormalities to improve reproductive health. The market also addresses prevalent issues like osteoporosis and chronic liver disease, often linked to calcium or vitamin D shortages and hepatitis B virus (HBV). With rising concerns over SARS-CoV-2 and other infectious diseases, the market is witnessing the development of rapid diagnostic tests and portable point-of-care devices. Collaborations and partnerships, such as Hologic's Project Health Equality, aim to reduce disparities in healthcare quality and enhance cancer detection rates, including for ovarian cancer and colon cancer.
The market encompasses a wide array of areas in medical science, including AIDS management, osteoporosis prevalence, and Mycobacterium TB illness detection. It also focuses on the prenatal segment for monitoring maternal health and fetal development. Diagnostic centers play a crucial role, offering services for various conditions such as ovarian, uterine, and vaginal infections. Technologies like portable and point-of-care devices enhance accessibility to healthcare. The market addresses chronic and lifestyle-related disorders like obesity, drug abuse, and alcohol use through advanced diagnostics. Collaborations with institutions like the Census Bureau and NIH drive research on fertility rates and reproductive age for better breast cancer management, including testing for benign breast lesions.
Market Scope |
|
Report Coverage |
Details |
Page number |
181 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.93% |
Market growth 2023-2027 |
USD 13.35 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.95 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Canada, France, UK, and China |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Danaher Corp., Exact Sciences Corp., F. Hoffmann La Roche Ltd., FUJIFILM Corp., GE Healthcare Technologies Inc., Hologic Inc., Illumina Inc., Invitae Corp., Myriad Genetics Inc., Natera Inc., PerkinElmer Inc., QIAGEN NV, Quest Diagnostics Inc., Quidelortho Corp., Siemens AG, Thermo Fisher Scientific Inc., and Koninklijke Philips N.V. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.